Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Appointed director
Director comp.
Acq. announced
Director departure
RHYTHM PHARMACEUTICALS, INC. (RYTM) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/03/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/03/2023 SC 13G BlackRock Inc. reports a 6.6% stake in RHYTHM PHARMACEUTICALS INC
07/08/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/24/2022 SC 13G GOLDMAN SACHS GROUP INC reports a 6.1% stake in RHYTHM PHARMACEUTICALS, INC.
02/12/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/07/2020 SC 13G BlackRock Inc. reports a 5.8% stake in RHYTHM PHARMACEUTICALS INC
01/28/2020 SC 13G WELLINGTON MANAGEMENT GROUP LLP reports a 7.6% stake in Rhythm Pharmaceutica
08/19/2019 SC 13G Flynn James E reports a 5.1% stake in Rhythm Pharmaceuticals, Inc.
02/14/2019 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/12/2019 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/13/2018 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/13/2018 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/18/2017 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/10/2017 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy